pLenti CMV V5-LUC Blast (w567-1) Citations (23)
Originally described in: A Versatile Viral System for Expression and Depletion of Proteins in Mammalian CellsCampeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. PLoS One. 2009 Aug 6;4(8):e6529. PubMed Journal
Articles Citing pLenti CMV V5-LUC Blast (w567-1)
| Articles |
|---|
| Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis. Saldana SM, Lee HH, Lowery FJ, Khotskaya YB, Xia W, Zhang C, Chang SS, Chou CK, Steeg PS, Yu D, Hung MC. PLoS One. 2013 Sep 5;8(9):e73406. doi: 10.1371/journal.pone.0073406. eCollection 2013. PubMed |
| Nuclear redox imbalance affects circadian oscillation in HaCaT keratinocytes. Ranieri D, Avitabile D, Shiota M, Yokomizo A, Naito S, Bizzarri M, Torrisi MR. Int J Biochem Cell Biol. 2015 Aug;65:113-24. doi: 10.1016/j.biocel.2015.05.018. Epub 2015 May 28. PubMed |
| Use of a Closed Culture System to Improve the Safety of Lentiviral Vector Production. Wu T, Bour G, Durand S, Lindner V, Gosse F, Zona L, Certoux JM, Diana M, Baumert TF, Marescaux J, Mutter D, Pessaux P, Robinet E. Hum Gene Ther Methods. 2015 Dec;26(6):197-210. doi: 10.1089/hgtb.2015.080. Epub 2015 Nov 10. PubMed |
| Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. Hashimoto S, Mikami S, Sugino H, Yoshikawa A, Hashimoto A, Onodera Y, Furukawa S, Handa H, Oikawa T, Okada Y, Oya M, Sabe H. Nat Commun. 2016 Feb 8;7:10656. doi: 10.1038/ncomms10656. PubMed |
| P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance. Hashimoto A, Oikawa T, Hashimoto S, Sugino H, Yoshikawa A, Otsuka Y, Handa H, Onodera Y, Nam JM, Oneyama C, Okada M, Fukuda M, Sabe H. J Cell Biol. 2016 Apr 11;213(1):81-95. doi: 10.1083/jcb.201510002. Epub 2016 Apr 4. PubMed |
| Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma. Benhamou Y, Picco V, Raybaud H, Sudaka A, Chamorey E, Brolih S, Monteverde M, Merlano M, Lo Nigro C, Ambrosetti D, Pages G. Oncotarget. 2016 Jul 12;7(28):44236-44251. doi: 10.18632/oncotarget.10005. PubMed |
| Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle. Stilhano RS, Madrigal JL, Wong K, Williams PA, Martin PK, Yamaguchi FS, Samoto VY, Han SW, Silva EA. J Control Release. 2016 Sep 10;237:42-9. doi: 10.1016/j.jconrel.2016.06.047. Epub 2016 Jul 1. PubMed |
| ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance. Hashimoto A, Hashimoto S, Sugino H, Yoshikawa A, Onodera Y, Handa H, Oikawa T, Sabe H. Oncogenesis. 2016 Sep 12;5(9):e259. doi: 10.1038/oncsis.2016.60. PubMed |
| SPRTN is a mammalian DNA-binding metalloprotease that resolves DNA-protein crosslinks. Lopez-Mosqueda J, Maddi K, Prgomet S, Kalayil S, Marinovic-Terzic I, Terzic J, Dikic I. Elife. 2016 Nov 17;5. pii: e21491. doi: 10.7554/eLife.21491. PubMed |
| Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells. MacLeod G, Bozek DA, Rajakulendran N, Monteiro V, Ahmadi M, Steinhart Z, Kushida MM, Yu H, Coutinho FJ, Cavalli FMG, Restall I, Hao X, Hart T, Luchman HA, Weiss S, Dirks PB, Angers S. Cell Rep. 2019 Apr 16;27(3):971-986.e9. doi: 10.1016/j.celrep.2019.03.047. PubMed |
A lineage-tracing tool to map the fate of hypoxic tumour cells.
Vermeer JAF, Ient J, Markelc B, Kaeppler J, Barbeau LMO, Groot AJ, Muschel RJ, Vooijs MA.
Dis Model Mech. 2020 Jul 30;13(7). pii: dmm.044768. doi: 10.1242/dmm.044768.
PubMed
Associated Plasmids |
| Dynamic High-Sensitivity Quantitation of Procollagen-I by Endogenous CRISPR-Cas9 NanoLuciferase Tagging. Calverley BC, Kadler KE, Pickard A. Cells. 2020 Sep 10;9(9). pii: cells9092070. doi: 10.3390/cells9092070. PubMed |
| Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer. Zhang J, Ying Y, Li M, Wang M, Huang X, Jia M, Zeng J, Ma C, Zhang Y, Li C, Wang X, Shu XS. Theranostics. 2020 Aug 8;10(22):10016-10030. doi: 10.7150/thno.47081. eCollection 2020. PubMed |
| Seroprevalence of SARS-CoV-2 antibodies among rural healthcare workers. Neises JZ, Hossain MS, Sultana R, Wanniarachchi KN, Wollman JW, Nelson E, Specker BL, Hoppe AD, Lawson SR, Thiex NW. J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27224. PubMed |
| IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. Tulotta C, Lefley DV, Moore CK, Amariutei AE, Spicer-Hadlington AR, Quayle LA, Hughes RO, Ahmed K, Cookson V, Evans CA, Vadakekolathu J, Heath P, Francis S, Pinteaux E, Pockley AG, Ottewell PD. NPJ Breast Cancer. 2021 Jul 21;7(1):95. doi: 10.1038/s41523-021-00305-w. PubMed |
| Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes. Spenle C, Loustau T, Burckel H, Riegel G, Abou Faycal C, Li C, Yilmaz A, Petti L, Steinbach F, Ahowesso C, Jost C, Paul N, Carapito R, Noel G, Anjuere F, Salome N, Orend G. Front Immunol. 2021 Jul 5;12:636108. doi: 10.3389/fimmu.2021.636108. eCollection 2021. PubMed |
| The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway. Nyati KK, Hashimoto S, Singh SK, Tekguc M, Metwally H, Liu YC, Okuzaki D, Gemechu Y, Kang S, Kishimoto T. Cancer Lett. 2021 Nov 1;520:295-306. doi: 10.1016/j.canlet.2021.08.004. Epub 2021 Aug 10. PubMed |
| ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapy. Ianniciello A, Zarou MM, Rattigan KM, Scott M, Dawson A, Dunn K, Brabcova Z, Kalkman ER, Nixon C, Michie AM, Copland M, Vetrie D, Ambler M, Saxty B, Helgason GV. Sci Transl Med. 2021 Sep 29;13(613):eabd5016. doi: 10.1126/scitranslmed.abd5016. Epub 2021 Sep 29. PubMed |
| Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma. Glennon KI, Maralani M, Abdian N, Paccard A, Montermini L, Nam AJ, Arseneault M, Staffa A, Jandaghi P, Meehan B, Brimo F, Tanguay S, Rak J, Riazalhosseini Y. Cancers (Basel). 2021 Nov 20;13(22). pii: cancers13225825. doi: 10.3390/cancers13225825. PubMed |
| Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma. Filipponi D, Pagnuzzi-Boncompagni M, Pages G. Cancers (Basel). 2022 Apr 22;14(9). pii: cancers14092095. doi: 10.3390/cancers14092095. PubMed |
| Tumor-derived CTF1 (cardiotrophin 1) is a critical mediator of stroma-assisted and autophagy-dependent breast cancer cell migration, invasion and metastasis. Akkoc Y, Dalci K, Karakas HE, Erbil-Bilir S, Yalav O, Sakman G, Celik F, Arikan S, Zeybek U, Ergin M, Akkiz H, Dilege E, Dengjel J, Dogan-Ekici AI, Gozuacik D. Autophagy. 2022 Jun 28:1-18. doi: 10.1080/15548627.2022.2090693. PubMed |
| Overexpression of estrogen receptor GPER1 and G1 treatment reduces SARS-CoV-2 infection in BEAS-2B bronchial cells. Costa AJ, Lemes RMR, Bartolomeo CS, Nunes TA, Pereira GC, Oliveira RB, Gomes AL, Smaili SS, Maciel RMB, Newson L, Ramirez AL, Okuda LH, Prado CM, Stilhano RS, Ureshino RP. Mol Cell Endocrinol. 2022 Dec 1;558:111775. doi: 10.1016/j.mce.2022.111775. Epub 2022 Sep 9. PubMed |
| Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2. Miluzio A, Cuomo A, Cordiglieri C, Donnici L, Pesce E, Bombaci M, Conti M, Fasciani A, Terracciano L, Manganaro L, Toccafondi M, Scagliola A, Oliveto S, Ricciardi S, Grifantini R, De Francesco R, Abrignani S, Manfrini N, Biffo S. EBioMedicine. 2023 Jan;87:104390. doi: 10.1016/j.ebiom.2022.104390. Epub 2022 Dec 28. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.